Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [339]

Durvalumab and tremelimumab show manageable safety in poor-prognosis HCC

Prof Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong

Durvalumab and tremelimumab show manageable safety in poor-prognosis HCC ( Prof Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract...

Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt...

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer ( Dr Thorsten Oliver Goetze - The University Cancer Center (UCT), Frankfurt, Germany )

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic...

Dr Vincent Picozzi - Virginia Mason Medical Center, Seattle, USA

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer ( Dr Vincent Picozzi - Virginia Mason Medical Center, Seattle, USA )

Characteristics associated with longer-term OS with NALIRIFOX regimen in...

Dr Vincent Chung - City of Hope, Duarte, USA

Characteristics associated with longer-term OS with NALIRIFOX regimen in metastatic pancreatic adenocarcinoma ( Dr Vincent Chung - City of Hope, Duarte, USA )

Gemcitabine/nab-paclitaxel compared with 5-fluorouracil/leucovorin/liposomal...

Dr Efrat Dotan - University of Pennsylvania, Philadelphia, USA

Gemcitabine/nab-paclitaxel compared with 5-fluorouracil/leucovorin/liposomal irinotecan shows similar results in older patients ( Dr Efrat Dotan - University of Pennsylvania, Philadelphia, USA )

Expectations and priorities of older patients with cancer: the PRIORITY...

Dr Camille Chakiba - Institute Bergonié, Bordeaux, France

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study ( Dr Camille Chakiba - Institute Bergonié, Bordeaux, France )

Cabozantinib demonstrates significant improvement in PFS by BICR in advanced...

Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA

Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours ( Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA )

Selecting patients wisely for neoadjuvant therapy in HPB cancers

Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India

Selecting patients wisely for neoadjuvant therapy in HPB cancers ( Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India )

TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate...

Prof Josep Llovet - Hospital Clinic Barcelona, Barcelona, Spain

TACE combined with lenvatinib-pembrolizumab shows improved PFS in intermediate stage liver cancer ( Prof Josep Llovet - Hospital Clinic Barcelona, Barcelona, Spain )

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )

Association of adult attachment with delays in accessing specialist care in...

Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer ( Dr Soumitra S. Datta - Tata Medical Center, Kolkata, India )

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )

More from ecancer